Healthcare Industry News:  hyperthermia therapy 

Devices Oncology

 News Release - September 29, 2009

BSD Medical Corporation Sells Hyperthermia System to University of California, San Francisco Medical Center

SALT LAKE CITY, Sept., 29--(HSMN NewsFeed)--BSD Medical Corporation (NASDAQ: BSDM ) (www.BSDMedical.com) announced today that the University of California, San Francisco Medical Center (UCSF) has acquired a BSD-500 Hyperthermia System (BSD-500). UCSF is a world leader in hyperthermia and has the largest and most versatile hyperthermia program on the West Coast, and its world-renowned Radiation Oncology team has added the capabilities of the BSD-500 to its growing hyperthermia cancer treatment program.

According to the UCSF hyperthermia website, the UCSF hyperthermia team tailors treatment to meet the needs of each individual patient. Information on its innovative hyperthermia program can be found at: http://radonc.ucsf.edu /treatment_programs/ hyperthermia.html. The UCSF Radiation Oncology team offers a comprehensive approach to patient care and is world-renowned for providing the highest level of care to cancer patients. UCSF is committed to the practice of evidence-based medicine, and the UCSF team continually finds new and better treatment options that improve patient outcomes in the treatment of cancer.

The BSD-500 Hyperthermia System is approved by the Food and Drug Administration to deliver therapeutic heat (hyperthermia) alone or in conjunction with radiotherapy to treat certain malignant tumors by the use of either external or interstitial application of energy. The BSD-500 has been used extensively to treat patients with recurrent breast cancer. Previous studies have demonstrated that hyperthermia in conjunction with radiation significantly improved local tumor control in recurrent breast cancer patients and may improve survival in some patients.

Including the system sold to UCSF, the Company sold seven BSD-500 Hyperthermia Systems during its fiscal year ended August 31, 2009, including five systems in the United States and two systems internationally. These domestic sales are further evidence of the growing use of hyperthermia therapy in the United States.

About UCSF

UCSF is a world leader in health care, known for innovative medicine, advanced technology and compassionate care (ucsfhealth.org). UCSF Medical Center is one of the top 10 hospitals in the nation, and a leader in the medical innovations that have improved and saved lives. UCSF has the only nationally designated Comprehensive Cancer Center in Northern California. The center is dedicated to finding new and better treatments for cancer patients. UCSF operates two San Francisco medical centers and 75 clinics that handle more than 1 million patients per year. UCSF Medical Center, which has some 900 physicians on its staff, also participates in a variety of clinical studies.

About BSD Medical Corporation

BSD Medical Corp. is a leading developer of systems used to deliver precision-focused microwave/RF energy to diseased sites in the body, including cancer. Its treatments are used to kill cancer directly and increase the effectiveness of companion radiation treatments for certain tumors. For further information visit BSD Medical's website at www.BSDMedical.com.

Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.


Source: BSD Medical

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.